SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000950123-19-008820
Filing Date
2019-09-06
Accepted
2019-09-06 17:14:33
Documents
3

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 45333
2 GRAPHIC g637051g21x81.jpg GRAPHIC 4317
3 GRAPHIC g637051g33u12.jpg GRAPHIC 3240
  Complete submission text file 0000950123-19-008820.txt   56955
Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Filer) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2836 Biological Products, (No Diagnostic Substances)